IDEAYA Biosciences (IDYA) Return on Capital Employed (2019 - 2026)
IDEAYA Biosciences (IDYA) reported Return on Capital Employed of 18.26% for Q1 2026, up 1569.0% on a YoY basis from 1.09% in Q1 2025, and down 24.72% sequentially from 14.64% in Q4 2025.
IDEAYA Biosciences (IDYA) Return on Capital Employed (2019 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 8 years of Return on Capital Employed data on file, last reported at 18.26% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 1569.0% year-over-year to 18.26%; the trailing twelve-month figure through Mar 2026 stood at 18.26% (up 1569.0% YoY), and the FY2025 full-year result was 15.06%, up 2384.0% from the prior year.
- Return on Capital Employed retreated to 18.26% in Q1 2026, from 14.64% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 14.64% in Q4 2025 to a low of 37.83% in Q2 2025.
- A 5-year average of 22.24% and a median of 20.65% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed slumped 1718 bps in 2025 and soared 1569 bps in 2026, its largest moves.
- Tracing IDYA's Return on Capital Employed over 5 years: stood at 17.0% in 2022, then slumped by 40 bps to 23.83% in 2023, then decreased by 21 bps to 28.79% in 2024, then jumped by 49 bps to 14.64% in 2025, then fell by 25 bps to 18.26% in 2026.
- Business Quant data shows IDYA's Return on Capital Employed at 18.26% in Q1 2026, 14.64% in Q4 2025, and 19.92% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - | -18.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.26% |
| Dec 31, 2025 | -14.64% |
| Sep 30, 2025 | -19.92% |
| Jun 30, 2025 | -37.83% |
| Mar 31, 2025 | -33.95% |
| Dec 31, 2024 | -28.79% |
| Sep 30, 2024 | -21.08% |
| Jun 30, 2024 | -20.65% |
| Mar 31, 2024 | -20.39% |
| Dec 31, 2023 | -23.83% |
| Sep 30, 2023 | -23.54% |
| Jun 30, 2023 | -20.14% |
| Mar 31, 2023 | -21.52% |
| Dec 31, 2022 | -17.00% |
| Sep 30, 2022 | -15.93% |
| Jun 30, 2022 | -23.01% |
| Mar 31, 2022 | -17.68% |
| Dec 31, 2021 | -14.56% |
| Sep 30, 2021 | -11.43% |
| Jun 30, 2021 | -10.45% |